Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Metabolic Cofactor Supplementation in Alzheimer's Disease (AD) and Parkinson's Disease (PD) Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04044131
Recruitment Status : Recruiting
First Posted : August 5, 2019
Last Update Posted : February 13, 2020
Sponsor:
Collaborators:
ScandiBio Therapeutics AB
Alanya Alaaddin Keykubat University
Sahlgrenska University Hospital, Sweden
KTH Royal Institute of Technology
Information provided by (Responsible Party):
Prof. Lutfu Hanoglu, MD, Istanbul Medipol University Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 2020
Estimated Study Completion Date : September 2020